By ISOPP & BOPA on 24th October 2025

International Pharmacy Debate: Pharmacogenomics is Over-Rated (COSA CPG, CAPhO, ISOPP and BOPA)

Members are invited  to join an exciting international pharmacy debate: “Pharmacogenomics is Over-Rated” presented in collaboration with the Canadian Association of Pharmacy in Oncology (CAPhO), International Society of Oncology Pharmacy Practitioners (ISOPP), British…

Read article
By BOPA Executive Committee on 7th October 2025

BOPA 2025 Annual Report NOW Published

BOPA Annual Report 2025 – BOPA Welcome to the 2025 BOPA Annual Report. The last year has been another excellent year for BOPA. As you can see from our report…

Read article
By BOPA Committee on 30th September 2025

BSH – The Lymphoma special interest group are seeking to recruit one Pharmacist to their committee

After ongoing collaboration between BOPA and BSH, the BSH Lymphoma special interest group are seeking to recruit one Pharmacist to their committee. The committee provides a supportive network for clinicians in lymphoma…

Read article
By BOPA Executive Committee on 26th September 2025

CAPhO Oncology Fundamentals Day (OFD) 2025: Saturday, October 18, 2025, 10:00 – 19:00 EDT

CAPhO Oncology Fundamentals Day (OFD) 2025: Saturday, October 18, 2025, 10:00 – 19:00 EDT Are you a pharmacist or technician new to oncology practice? Are you a pharmacy student or…

Read article
By BOPA Executive Committee on 22nd September 2025

Highlights of ISOPP CAPhO Symposium 2025 Webinar Friday, September 26 at 22:30 (BST)

Members are invited to participate in the Highlights of ISOPP CAPhO Symposium 2025 Webinar hosted by the Canadian Association of Pharmacy in Oncology (CAPhO) and produced in collaboration with the International Society of Oncology Pharmacy…

Read article
By Joseph Williams on 22nd September 2025

Ensuring Quality and Equity in Cancer Treatment – UICC & ISOPP Joint Statement

BOPA have endorsed the UICC & ISOPP Joint Statement ‘Ensuring Quality and Equity in Cancer Treatment’ The alarming findings reported in The Lancet Global Health reveal that approximately one in…

Read article
By UK SACT Board Representatives - Joseph Williams and Netty Cracknell on 16th September 2025

Proposals for the reshaping of cancer services in England: funding for innovative cancer treatments

The Royal College of Radiologists (RCR) and the Society of Radiographers (SoR) have published a short document that expands on previous proposals for improving funding arrangements to enable equitable access…

Read article
By Hannah Miller on 4th September 2025

British Journal of Haematology Publication – BOPA Member Hannah Miller

Assessment and treatment of frail patientns living with multiple myeloma. A guideline on behalf of the UK Myeloma Research Alliance Frailty Group Enjoy an article published in the British Journal…

Read article
By BOPA Podcast Team on 27th August 2025

BOPA’s Let’s Talk About SACT Podcast – Number 16 top podcast in cancer and number 6 oncology podcast in the UK

BOPA is ecstatic to announce that the “Let’s Talk About SACT” podcast has been selected by FeedSpot panellists as one of the Top 35 UK Cancer Podcasts on the web. It…

Read article
By Catherine Loughran on 27th August 2025

New BSH (British Society of Haematology) Supportive Care, Specialist Interest group

New BSH (British Society of Haematology) Supportive Care, Specialist Interest group Are you a BSH member passionate about improving supportive care in haematology? Do you want to help shape the…

Read article
By BOPA Executive Committee on 20th August 2025

Macmillan Cancer Support – We are always looking for Specialist Cancer pharmacists to join our review panel

Macmillan Cancer Support produces many cancer drug treatment pages. These page are widely used by healthcare professionals and people affected by cancer across the UK. We work hard to ensure…

Read article
By BOPA Executive Committee on 18th August 2025

BOPA 2025 Executive Committee Election – Its time to cast your vote!

Thank you to all of our nominees this year – we really appreciate your nominations for the Executive Committee.  Summary of nominations: In 2025 we received 4 nominations for 2…

Read article